Additional Metadata
Persistent URL dx.doi.org/10.1016/s0140-6736(19)31240-1, hdl.handle.net/1765/118204
Journal The Lancet
Rights no access
Citation
Moreau, P, Attal, M, Hulin, C, Arnulf, B., Belhadj, K., & Benboubker, L. (2019). Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. The Lancet, 394(10192), 29–38. doi:10.1016/s0140-6736(19)31240-1